Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 15 min ago
PreprintCC BY-NC-NDbioRxiv

ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesisand fatty acid oxidation in colorectal cancer

1 more authors
  1. 1Stanford University

Abstract

Metabolic reprogramming is a hallmark of cancer cells, and stem-like populations often upregulate aldehyde dehydrogenases (ALDHs). Functional studies have established essential roles for individual ALDH isoforms in tumor initiation, progression, and metastasis; however, the mechanisms by which these enzymes promote malignancy remain poorly understood. Here we show that aldehyde dehydrogenase 1B1 (ALDH1B1), a mitochondrial enzyme highly expressed in colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC), generates {gamma}-butyrobetaine (GBB) and {gamma}-aminobutyric acid (GABA) in CRC cells. The biosynthesis of both aminocarboxylic acids has been attributed to the cytosolic enzyme ALDH9A1, and we demonstrate that mitochondrial GBB and GABA are functionally distinct from the cytosolic pools of these metabolites. We further demonstrate that mitochondrial GBB can function as an antiport substrate of carnitine-acylcarnitine translocase (CACT), the transporter that mediates fatty acid uptake into the mitochondrial inner matrix. This activity complements the role of cytosolic GBB as the biosynthetic precursor to carnitine. Accordingly, ALDH1B1 can markedly enhance mitochondrial fatty acid oxidation (FAO), a catabolic process that has been linked to CRC and PDAC stemness, progression, and metastasis. Our findings reveal an unexpected role for ALDH1B1 in carnitine metabolism, GABA biosynthesis, and FAO and illustrate how the compartmental reprogramming of metabolic pathways can promote tumor growth.

Related

  1. Constitutive PI3K-AKT activation promotes steatohepatitis through de novo lipogenesis despite enhanced mitochondrial β-oxidation, essential fatty acid depletion and reduced lipid peroxidation
    A. S. Peixoto, E. Castro, B. F. Leonardi +16
    bioRxivPreprintAll rights reservedFull textEpidemiology & public healthbioRxiv
  2. A Tumor-Pituitary-Stromal Axis Promotes Colorectal Cancer Progression
    W. Li, S. Wang, H. Wu +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Lactylation-driven mitochondrial dysfunction promotes diabetic myocardial fibrosis via impairing mitophagy and activating TGF-β1
    Bing Lian, Junyan Li, Yonglong Guo +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicineCrossref
  4. Fatty acid oxidation impairment in diabetic kidney disease: a bidirectional feedback network from mitochondrial quality control to systemic regulation
    Yuanxin Jiang, Wudi Zhang, Danmai Zhao +2
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMCPMCEurope PMC
  5. Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension with HADHA-associated improvements in fatty acid oxidation and mitochondrial redox homeostasis
    Xinyu Bai, Keke Tian, Shiyuan Song +6
    Redox BiologyPeer-reviewedCC BYFull textMolecular biology & gene regulationGeneral biologyDOAJ
BibTeX
@misc{feng2026aldh1b1,
  title = {{ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesisand fatty acid oxidation in colorectal cancer}},
  author = {Z. Feng and T. E. Bearrood and S. L. Campbell and A. M. Kinsey and N. Matulionis and C.-H. Chen and T. Seike and L. Leak and A. K. Tarhan and S. J. Dixon and D. Mochly-Rosen and H. R. Christofk and J. K. Chen},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.24.753323},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.24.753323v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - ALDH1B1 promotes mitochondrial γ-butyrobetaine biosynthesisand fatty acid oxidation in colorectal cancer
AU  - Z. Feng
AU  - T. E. Bearrood
AU  - S. L. Campbell
AU  - A. M. Kinsey
AU  - N. Matulionis
AU  - C.-H. Chen
AU  - T. Seike
AU  - L. Leak
AU  - A. K. Tarhan
AU  - S. J. Dixon
AU  - D. Mochly-Rosen
AU  - H. R. Christofk
AU  - J. K. Chen
PY  - 2026
DA  - 2026/09/24
PB  - bioRxiv
DO  - 10.64898/2026.09.24.753323
UR  - https://www.biorxiv.org/content/10.64898/2026.09.24.753323v1
AB  - Metabolic reprogramming is a hallmark of cancer cells, and stem-like populations often upregulate aldehyde dehydrogenases (ALDHs). Functional studies have established essential roles for individual ALDH isoforms in tumor initiation, progression, and metastasis; however, the mechanisms by which these enzymes promote malignancy remain poorly understood. Here we show that aldehyde dehydrogenase 1B1 (ALDH1B1), a mitochondrial enzyme highly expressed in colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC), generates {gamma}-butyrobetaine (GBB) and {gamma}-aminobutyric acid (GABA) in CRC cells. The biosynthesis of both aminocarboxylic acids has been attributed to the cytosolic enzyme ALDH9A1, and we demonstrate that mitochondrial GBB and GABA are functionally distinct from the cytosolic pools of these metabolites. We further demonstrate that mitochondrial GBB can function as an antiport substrate of carnitine-acylcarnitine translocase (CACT), the transporter that mediates fatty acid uptake into the mitochondrial inner matrix. This activity complements the role of cytosolic GBB as the biosynthetic precursor to carnitine. Accordingly, ALDH1B1 can markedly enhance mitochondrial fatty acid oxidation (FAO), a catabolic process that has been linked to CRC and PDAC stemness, progression, and metastasis. Our findings reveal an unexpected role for ALDH1B1 in carnitine metabolism, GABA biosynthesis, and FAO and illustrate how the compartmental reprogramming of metabolic pathways can promote tumor growth.
ER  -